TBHC Q1 2026 Earnings EPS Misses Expectations as Loss Widens BH Q1 2025 Earnings EPS of 2337 Reported Amid Limited Disclosure CQP Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Operational Headwinds Weigh Halozyme Therapeutics Q1 2026 Earnings EPS Beat Drives Modest Positive Surprise Despite Flat Revenue Disclosure Damora Therapeutics Q1 2026 Earnings WiderThanExpected Loss Despite Stock Gain Standard Motor Products SMP Q1 2026 Earnings EPS Surpasses Estimates by 678 Despite Unreported Revenue